NCT02832362View on ClinicalTrials.gov

Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 11, 2016

Primary Completion Date

July 10, 2016

Study Completion Date

July 18, 2016

Conditions

Common Cold

Interventions

DRUG

Carbomer 980

Test product containing 0.5% carbomer 980 gel

OTHER

Placebo

Reference product containing vehicle without 0.5% carbomer 980 gel

Trial Locations (1)

G1P 0A2

GSK Investigational Site, Québec

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY